Bruker Announces Agreement for the Acquisition of Alicona Imaging GmbH

Bruker Corporation today announced that it has signed an agreement to purchase 100% of the shares of Alicona Imaging GmbH

Acquisition Strengthens Bruker’s Product Offerings in Optical Metrology

BILLERICA, Massachusetts, November 14, 2018 -- Bruker Corporation today announced that it has signed an agreement to purchase 100% of the shares of Alicona Imaging GmbH, a leading provider of optical-based metrology products based in Graz, Austria. Alicona’s optical 3D metrology products are a perfect complement to Bruker’s microCT, stylus profiler, white-light interferometry and atomic force microscope (AFM) product suite. The combined product offering broadens Bruker’s application reach and offers customers an even more comprehensive selection of complementary metrology solutions to serve their materials research, engineering and high-precision quality assurance needs. Financial details of the transaction were not disclosed. 

“We are excited to add Alicona’s unique technologies and strong brand to our set of metrology systems,” said Dr. Mark R. Munch, Bruker NANO Group President. “Alicona has led the industry in the development of focus variation technology and has delivered high-quality metrology products and manufacturing QA/QC solutions to the market that align nicely with our own products and our strengths in industrial metrology.” “We are very pleased to join Bruker,” added Dr. Stefan Scherer, co-CEO of Alicona. “We have built a strong company that delivers superior measurement solutions in laboratory and production environments, and we are looking forward to leveraging Bruker’s global reach to serve an even wider customer base and help expand the Bruker portfolio to a wider set of manufacturing solutions.” 

“We have focused for 17 years on building the highest quality products and best-matched solutions to our customers’ metrology problems,” explained Dr. Manfred Prantl, co-CEO of Alicona. “The Alicona InfiniteFocus, µCMM, and collaborative robot products are leading examples of this innovative history that combine nicely into Bruker’s growing family of application-enabling technologies.” “Over the last years Alicona has shown an impressive top-line growth and international expansion based on its leading technology,” said Philipp Jacobi, Managing Partner of Quadriga Capital Eigenkapitalberatung GmbH. “We are glad to have supported Alicona and its management team in such an important growth phase. 

Over the last 3 years Alicona’s staff has almost doubled to over 150 employees and its product portfolio has significantly expanded. With Bruker, Alicona gains a strong industrial research and metrology partner and at the same time a new home, from where the company can continue its international growth plans.” 

Forward Looking Statements for Bruker Corporation 

Any statements contained in this press release related to Bruker, Alicona Imaging GmbH and the acquisition of Alicona Imaging GmbH by Bruker which do not describe historical facts may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are often identified by qualifiers such as “expect,” “anticipate,” “will,” and similar expressions. Any forward-looking statements contained in this press release are based on Bruker’s current expectations, but are subject to risks and uncertainties that could cause actual results to differ materially from those indicated. Forward-looking statements in this communication include, among other things, statements about the potential benefits of the transaction, Bruker’s plans, objectives, expectations and intentions, and the financial condition, results of operations and business of Bruker following the completion of the proposed transaction. Risks and uncertainties include, among other things, risks and uncertainties relating to the consummation of the proposed acquisition on the proposed terms and schedule; Bruker’s financial and operational performance following the completion of the proposed transaction; Bruker’s ability to successfully integrate the business and realize the strategic and other benefits of the acquisition; the timing of when the acquisition will be accretive to earnings; and other risk factors identified and described in Bruker’s filings with the Securities and Exchange Commission, including, without limitation, Bruker’s annual report on Form 10-K for the year ended December 31, 2017 and subsequently filed Quarterly Reports on Form 10-Q. Bruker expressly disclaims any intent or obligation to update these forward-looking statements other than as required by law. 

About Alicona Imaging GmbH 

Alicona is a global supplier of optical 3D surface measurement solutions for quality assurance in the lab and in production. Their key competence is the measurement of form and roughness of even complex, miniaturized geometries. The stable and robust technology of Alicona Focus-Variation delivers repeatable and traceable measurements even in a production environment. Research and Development acts very closely to the direct need of industry, which enables Alicona to design both standard products as well as special solutions based on industrial partnerships. Alicona headquarters is in Austria, with additional subsidiaries in Germany, France, UK, USA, South Korea and Italy. 

About Bruker Corporation (NASDAQ: BRKR) 

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. 

About Quadriga Capital 

The Quadriga Capital Funds invest into and support mid-size businesses in Germany, Austria, Switzerland and adjacent countries in the development and expansion of outstanding market positions. Portfolio companies of the Funds benefit from a broad practical knowledge and expert know-how as well as the industrial network. The Quadriga Capital Funds are focused on growth strategies for companies in the fields of smart industries, healthcare and services & software. Portfolio companies of the Funds are, amongst others, the Aspire Education Group from Vienna/Austria, Kinetics Holdings from south of Frankfurt and the GBA Laborgruppe from Hamburg.

Investor Contact:
T: +1 (978) 663-3660 x1479